Amedeo Smart

Free Medical Literature Service

 

Amedeo

Lung Cancer
  Free Subscription

Articles published in
Oncogene
    September 2025
  1. YANG M, Lu Y, Zheng J, Zhao X, et al
    PRICKLE3-USP9X interaction-mediated DVL2 deubiquitination promotes the progression of non-small cell lung cancer via canonical WNT pathway.
    Oncogene. 2025 Sep 19. doi: 10.1038/s41388-025-03580.
    >> Share

  2. PENG J, Zhang Q, Rao X, Allison DB, et al
    PLK1-mediated PDHA1 phosphorylation drives metabolic reprogramming in lung cancer.
    Oncogene. 2025 Sep 16. doi: 10.1038/s41388-025-03571.
    >> Share

  3. LIU L, Chen S, Lei Y, Lin Z, et al
    REPS2 attenuates cancer stemness through inhibiting Wnt signaling by autophagy mediated degradation of beta-catenin.
    Oncogene. 2025;44:2942-2955.
    >> Share

  4. ZHOU Y, Wang H, Tang S, He Y, et al
    Identification of RAPGEF3 as the therapeutic vulnerability of basal-subtype lung squamous cell carcinoma.
    Oncogene. 2025;44:3142-3148.
    >> Share

    August 2025
  5. LIN L, Chen L, Lin G, Chen X, et al
    Derlin-3 manipulates the endoplasmic reticulum stress and IgG4 secretion of plasma cells in lung adenocarcinoma.
    Oncogene. 2025;44:2620-2633.
    >> Share

  6. SHI R, Farnsworth DA, Febres-Aldana CA, Chow JLM, et al
    Drug tolerance and persistence to EGFR inhibitor treatment are mediated by an ILK-SFK-YAP signaling axis in lung adenocarcinoma.
    Oncogene. 2025;44:2831-2849.
    >> Share

    July 2025
  7. CAO K, Wei S, Ma T, Zou X, et al
    RFX2-BNIP3 axis-driven adaptive mitophagy promotes resistance to ACK1-targeted therapy in non-small cell lung cancer.
    Oncogene. 2025 Jul 25. doi: 10.1038/s41388-025-03502.
    >> Share

  8. WALLIS N, Gershon T, Shaaby S, Oberman F, et al
    AVJ16 inhibits lung carcinoma by targeting IGF2BP1.
    Oncogene. 2025 Jul 8. doi: 10.1038/s41388-025-03449.
    >> Share

  9. TAN X, Wu C, Banerjee P, Wang S, et al
    Dichotomous roles of ACBD3 in NSCLC growth and metastasis.
    Oncogene. 2025;44:2078-2090.
    >> Share

  10. TAKUMIDA H, Saito A, Okabe Y, Terasaki Y, et al
    Integrative epigenome and transcriptome analyses reveal transcriptional programs differentially regulated by ASCL1 and NEUROD1 in small cell lung cancer.
    Oncogene. 2025 Jul 1. doi: 10.1038/s41388-025-03481.
    >> Share

  11. OH YT, Chen Z, Wang D, Ramalingam SS, et al
    Induction of IL6/STAT3-dependent TRAIL expression that contributes to the therapeutic efficacy of osimertinib in EGFR mutant NSCLC cells.
    Oncogene. 2025;44:2315-2327.
    >> Share

    June 2025
  12. LI S, Lin J, Huang L, Hu S, et al
    STK31 drives tumor immune evasion through STAT3-IL-6 mediated CD8(+) T cell exhaustion.
    Oncogene. 2025;44:1452-1462.
    >> Share

  13. POIRIER A, Utecht T, Villot R, Gelinas Y, et al
    ZNF768 loss amplifies p53 action and reduces lung tumorigenesis in mice.
    Oncogene. 2025;44:1793-1804.
    >> Share

    May 2025
  14. WANG C, Zhang S, Ma B, Fu Y, et al
    Correction: TP53 mutations upregulate RCP expression via Sp1/3 to drive lung cancer progression.
    Oncogene. 2025 May 14. doi: 10.1038/s41388-025-03441.
    >> Share

  15. WANG T, Shen Z, Yang L, Zhang X, et al
    The coagulation and tumor system are directly linked through the proteolysis and activation of epidermal growth factor receptor by thrombin.
    Oncogene. 2025;44:1153-1166.
    >> Share

  16. ZHANG C, Zhou W, Xu H, Xu J, et al
    Cancer-associated fibroblasts promote EGFR-TKI resistance via the CTHRC1/glycolysis/H3K18la positive feedback loop.
    Oncogene. 2025;44:1400-1414.
    >> Share

    April 2025
  17. LIU X, Cui Y, Gong J, Yu X, et al
    SETD5 facilitates stemness and represses ferroptosis via m6A-mediating PKM2 stabilization in non-small cell lung cancer.
    Oncogene. 2025 Apr 30. doi: 10.1038/s41388-025-03426.
    >> Share

  18. GAO Y, Li B, Jin Y, Cheng J, et al
    Spatial multi-omics profiling of breast cancer oligo-recurrent lung metastasis.
    Oncogene. 2025 Apr 15. doi: 10.1038/s41388-025-03388.
    >> Share

  19. XU X, Wang S, Zhou H, Tan Q, et al
    Transcriptome-wide association study of alternative polyadenylation identifies susceptibility genes in non-small cell lung cancer.
    Oncogene. 2025 Apr 9. doi: 10.1038/s41388-025-03338.
    >> Share

    March 2025
  20. ZHANG S, Tan YQ, Zhang X, Basappa B, et al
    TFF3 drives Hippo dependent EGFR-TKI resistance in lung adenocarcinoma.
    Oncogene. 2025;44:753-768.
    >> Share

    February 2025
  21. LI H, Li Y, Zheng X, Chen F, et al
    RBM15 facilitates osimertinib resistance of lung adenocarcinoma through m6A-dependent epigenetic silencing of SPOCK1.
    Oncogene. 2025;44:307-321.
    >> Share

    January 2025
  22. ZEESHAN S, Dalal B, Arauz RF, Zingone A, et al
    Global profiling of alternative splicing in non-small cell lung cancer reveals novel histological and population differences.
    Oncogene. 2025 Jan 10. doi: 10.1038/s41388-024-03267.
    >> Share

  23. TYAGI A, Wu SY, Sharma S, Wu K, et al
    Retraction Note: Exosomal miR-4466 from nicotine-activated neutrophils promotes tumor cell stemness and metabolism in lung cancer metastasis.
    Oncogene. 2025 Jan 9. doi: 10.1038/s41388-024-03269.
    >> Share

    December 2024
  24. LEI Y, Zhong C, Zhang J, Zheng Q, et al
    Senescent lung fibroblasts in idiopathic pulmonary fibrosis facilitate non-small cell lung cancer progression by secreting exosomal MMP1.
    Oncogene. 2024 Dec 11. doi: 10.1038/s41388-024-03236.
    >> Share

  25. TANG T, Yang T, Xue H, Liu X, et al
    Breast cancer stem cell-derived exosomal lnc-PDGFD induces fibroblast-niche formation and promotes lung metastasis.
    Oncogene. 2024 Dec 4. doi: 10.1038/s41388-024-03237.
    >> Share

  26. CHEN Y, Zhu X, Wang J, Hu J, et al
    MAZ promotes tumor proliferation and immune evasion in lung adenocarcinoma.
    Oncogene. 2024;43:3619-3632.
    >> Share

    November 2024
  27. CHEN T, Ashwood LM, Kondrashova O, Strasser A, et al
    Breathing new insights into the role of mutant p53 in lung cancer.
    Oncogene. 2024 Nov 20. doi: 10.1038/s41388-024-03219.
    >> Share

  28. NIU Y, Tang Y, Ma F, Zhou X, et al
    Super-enhancer MYCNOS-SE promotes chemoresistance in small cell lung cancer by recruiting transcription factors CTCF and KLF15.
    Oncogene. 2024 Nov 8. doi: 10.1038/s41388-024-03202.
    >> Share

    September 2024
  29. LAILLER C, Didelot A, Garinet S, Berthou H, et al
    PrP(C) controls epithelial-to-mesenchymal transition in EGFR-mutated NSCLC: implications for TKI resistance and patient follow-up.
    Oncogene. 2024;43:2781-2794.
    >> Share

  30. HAN P, Zhang B, Li Y, Gao R, et al
    MiR-183-5p inhibits lung squamous cell carcinoma survival through disrupting hypoxia adaptation mediated by HIF-1alpha/NDUFA4L2 axis.
    Oncogene. 2024;43:2821-2834.
    >> Share

    August 2024
  31. NGUYEN A, Nunez CG, Tran TA, Girard L, et al
    Jumonji histone demethylases are therapeutic targets in small cell lung cancer.
    Oncogene. 2024 Aug 18. doi: 10.1038/s41388-024-03125.
    >> Share

  32. CHEN X, Zhou J, Wang Y, Wang X, et al
    PIM1/NF-kappaB/CCL2 blockade enhances anti-PD-1 therapy response by modulating macrophage infiltration and polarization in tumor microenvironment of NSCLC.
    Oncogene. 2024;43:2517-2530.
    >> Share

  33. SHEN NX, Luo MY, Gu WM, Gong M, et al
    GSTO1 aggravates EGFR-TKIs resistance and tumor metastasis via deglutathionylation of NPM1 in lung adenocarcinoma.
    Oncogene. 2024;43:2504-2516.
    >> Share

    July 2024
  34. WANG Z, Lei Z, Wang Y, Wang S, et al
    Bone-metastatic lung adenocarcinoma cells bearing CD74-ROS1 fusion interact with macrophages to promote their dissemination.
    Oncogene. 2024;43:2215-2227.
    >> Share

    June 2024
  35. JIN E, Wang S, Chen D, Wang JP, et al
    P4HA2 activates mTOR via hydroxylation and targeting P4HA2-mTOR inhibits lung adenocarcinoma cell growth.
    Oncogene. 2024;43:1813-1823.
    >> Share

  36. LI QQ, Guo M, He GH, Xi KH, et al
    VEGF-induced Nrdp1 deficiency in vascular endothelial cells promotes cancer metastasis by degrading vascular basement membrane.
    Oncogene. 2024;43:1836-1851.
    >> Share

  37. WANG K, Guo D, Yan T, Sun S, et al
    ZBTB16 inhibits DNA replication and induces cell cycle arrest by targeting WDHD1 transcription in lung adenocarcinoma.
    Oncogene. 2024;43:1796-1810.
    >> Share

  38. CHEN L, Zhang L, He H, Shao F, et al
    Ubiquitin-specific protease 54 regulates GLUT1-mediated aerobic glycolysis to inhibit lung adenocarcinoma progression by modifying p53 degradation.
    Oncogene. 2024;43:2025-2037.
    >> Share

    May 2024
  39. DORE S, Ali M, Sorin M, McDowell SAC, et al
    Exploring the prognostic significance of arm-level copy number alterations in triple-negative breast cancer.
    Oncogene. 2024 May 14. doi: 10.1038/s41388-024-03051.
    >> Share

    April 2024
  40. WANG X, Li X, Niu L, Lv F, et al
    FAK-LINC01089 negative regulatory loop controls chemoresistance and progression of small cell lung cancer.
    Oncogene. 2024 Apr 9. doi: 10.1038/s41388-024-03027.
    >> Share

  41. ZHANG T, Su F, Wang B, Liu L, et al
    Ubiquitin specific peptidase 38 epigenetically regulates KLF transcription factor 5 to augment malignant progression of lung adenocarcinoma.
    Oncogene. 2024;43:1190-1202.
    >> Share

    March 2024
  42. GUO J, Kim D, Gao J, Kurtyka C, et al
    Retraction Note: IKBKE is induced by STAT3 and tobacco carcinogen and determines chemosensitivity in non-small cell lung cancer.
    Oncogene. 2024 Mar 5. doi: 10.1038/s41388-024-02993.
    >> Share

  43. XU X, Qiu S, Zeng B, Huang Y, et al
    N(6)-methyladenosine demethyltransferase FTO mediated m(6)A modification of estrogen receptor alpha in non-small cell lung cancer tumorigenesis.
    Oncogene. 2024 Mar 5. doi: 10.1038/s41388-024-02992.
    >> Share

  44. KUMAR V, Yochum ZA, Devadassan P, Huang EH, et al
    TWIST1 is a critical downstream target of the HGF/MET pathway and is required for MET driven acquired resistance in oncogene driven lung cancer.
    Oncogene. 2024 Mar 1. doi: 10.1038/s41388-024-02987.
    >> Share

  45. MCCLELLAN B, Wilson CN, Brenner AJ, Jolly CA, et al
    Flotillin-1 palmitoylation is essential for its stability and subsequent tumor promoting capabilities.
    Oncogene. 2024;43:1063-1074.
    >> Share

  46. HEIM TE, Hankins ML, Belayneh R, Douglas N, et al
    RNA-sequencing predicts a role of androgen receptor and aldehyde dehydrogenase 1A1 in osteosarcoma lung metastases.
    Oncogene. 2024;43:1007-1018.
    >> Share

    February 2024
  47. GAROFALO M, Quintavalle C, Di Leva G, Zanca C, et al
    Editorial Expression of Concern: MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer.
    Oncogene. 2024 Feb 28. doi: 10.1038/s41388-024-02989.
    >> Share

  48. TURKOWSKI K, Herzberg F, Gunther S, Weigert A, et al
    miR-147b mediated suppression of DUSP8 promotes lung cancer progression.
    Oncogene. 2024 Feb 23. doi: 10.1038/s41388-024-02969.
    >> Share

    January 2024
  49. ZHANG Y, Liu L, Pei J, Ren Z, et al
    Tissue factor overexpression promotes resistance to KRAS-G12C inhibition in non-small cell lung cancer.
    Oncogene. 2024 Jan 8. doi: 10.1038/s41388-023-02924.
    >> Share

  50. OSER MG, MacPherson D, Oliver TG, Sage J, et al
    Genetically-engineered mouse models of small cell lung cancer: the next generation.
    Oncogene. 2024 Jan 8. doi: 10.1038/s41388-023-02929.
    >> Share

  51. MA M, Zhuang J, Li H, Mi R, et al
    Low expression of ZFP36L1 in osteosarcoma promotes lung metastasis by inhibiting the SDC4-TGF-beta signaling feedback loop.
    Oncogene. 2024;43:47-60.
    >> Share

    December 2023
  52. WANG L, Li H, Huang A, Zhao Y, et al
    Mutual regulation between TRIM21 and TRIM8 via K48-linked ubiquitination.
    Oncogene. 2023;42:3708-3718.
    >> Share

    November 2023
  53. CHEN W, Wang F, Yu X, Qi J, et al
    LncRNA MIR31HG fosters stemness malignant features of non-small cell lung cancer via H3K4me1- and H3K27Ace-mediated GLI2 expression.
    Oncogene. 2023 Nov 10. doi: 10.1038/s41388-023-02883.
    >> Share

  54. KOU F, Wu L, Zheng Y, Yi Y, et al
    HMGB1/SET/HAT1 complex-mediated SASH1 repression drives glycolysis and metastasis in lung adenocarcinoma.
    Oncogene. 2023;42:3407-3421.
    >> Share

  55. SUN X, Dai Y, He J, Li H, et al
    D-mannose induces TFE3-dependent lysosomal degradation of EGFR and inhibits the progression of NSCLC.
    Oncogene. 2023;42:3503-3513.
    >> Share

    October 2023
  56. BAI Y, Zhou L, Zhang C, Guo M, et al
    Dual network analysis of transcriptome data for discovery of new therapeutic targets in non-small cell lung cancer.
    Oncogene. 2023 Oct 20. doi: 10.1038/s41388-023-02866.
    >> Share

  57. LIU Y, Zhang T, Deng J, Huang Q, et al
    The cytotoxicity of (gammadelta)T cells in non-small cell lung cancer mediated via coordination of the BCL-2 and AKT pathways.
    Oncogene. 2023 Oct 7. doi: 10.1038/s41388-023-02852.
    >> Share

  58. WANG Y, Liu X, Wang M, Wang Y, et al
    UBE3B promotes breast cancer progression by antagonizing HIF-2alpha degradation.
    Oncogene. 2023 Oct 2. doi: 10.1038/s41388-023-02842.
    >> Share

  59. CUI P, Li J, Tao H, Li X, et al
    Deciphering pathogenic cellular module at single-cell resolution in checkpoint inhibitor-related pneumonitis.
    Oncogene. 2023;42:3098-3112.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016